First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer.
Oncologist
; 23(3): 297-305, 2018 03.
Article
in En
| MEDLINE
| ID: mdl-29133514
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Biomarkers, Tumor
/
Clinical Decision-Making
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Oncologist
Journal subject:
NEOPLASIAS
Year:
2018
Type:
Article
Affiliation country:
Italy